Bamlanivimab, Benzinga, Biotech, Coronavirus, COVID-19, General, Health Care, LLY, News, REGN, the National Institute of Allergy and Infectious Diseases, US5324571083, US75886F1075

NIAID Study Finds Eli Lilly’s Antibody Drug Unhelpful For Hospitalized COVID-19 Patients

Eli Lilly and Company (NYSE: LLY) said Monday that a trial of its antibody treatment for use in hospitalized COVID-19 patients has come to an end as the treatment is unlikely to help such patients. 
read more

1 2 3 269